GLP-1 drugs gain popularity for weight loss as usage trends rise, highlighting benefits and importance of lifestyle integration for long-term health outcomes
More Americans are increasingly using anti-obesity drugs, specifically GLP-1 medications, for weight loss and health improvement, with about 1 in 8 U.S. adults currently taking them. Since January, over 600,000 prescriptions for Novo Nordisk's new Wegovy pill have been issued, and early data indicates a significant portion of users are new to these medications. However, experts emphasize that medication alone is insufficient, stressing the necessity of combining GLP-1 drugs with lifestyle changes such as a healthy diet, exercise, adequate sleep, and stress management to achieve optimal and lasting benefits.
The growing adoption of GLP-1 drugs for weight management and health enhancement is a significant trend in the United States. A recent survey by the health research group KFF revealed that approximately one in eight adults in the U.S. are currently taking a GLP-1 drug. This surge in usage is further evidenced by the substantial number of prescriptions being written. For instance, Novo Nordisk reported that since the beginning of the year, more than 600,000 prescriptions have been dispensed for their new Wegovy pill. Truveta, a healthcare data company, has observed that early analysis suggests a notable portion of these users, over a third, are initiating treatment with these medications for the first time.
Despite the widespread use and reported effectiveness of these drugs, medical professionals are urging a more comprehensive approach. Experts caution that relying solely on medication is not the complete solution for achieving significant and sustained health improvements. They highlight that the most substantial benefits derived from GLP-1 medications are realized when they are integrated with fundamental lifestyle modifications. These essential changes include adopting a healthy diet, engaging in regular physical activity, ensuring sufficient sleep, and effectively managing stress levels.
Dr. Katherine Saunders, an expert in obesity medicine at Weill Cornell Medicine and a co-founder of FlyteHealth, a company focused on weight-loss treatments, articulates a common misconception. “The biggest mistake people make with GLP-1 medications is thinking the prescription is the treatment.”
The efficacy of GLP-1 drugs in promoting weight loss and improving health outcomes is well-documented. While these medications can induce positive changes independently, their impact is significantly amplified and their duration extended when used in conjunction with consistent lifestyle adjustments. This synergistic effect has been supported by a recent comprehensive review that analyzed nearly three dozen studies.
The article outlines key insights from experts regarding GLP-1 drugs and the importance of healthy habits. A central theme is that the focus should extend beyond mere weight reduction. Obesity is recognized as a major contributing factor to numerous chronic diseases, including heart disease and diabetes. Therefore, the ultimate goal should be the improvement of overall health rather than solely focusing on the numbers displayed on a scale.
Dr. Jody Dushay, an endocrinologist and obesity expert at Harvard Medical School, emphasizes this broader perspective on health. “Health is what you eat, how much you move your body, what is your blood sugar, what is your blood pressure, what is your cholesterol.”
“All of those things are really important.”
The mechanism by which GLP-1 drugs operate involves targeting specific hormones within the gut and brain. These hormones play a crucial role in regulating digestion, appetite, and the sensation of fullness. By influencing these hormonal pathways, the drugs effectively alter the body's signals related to hunger and satiety.
Dr. Saunders explains the impact of these drugs on an individual's ability to adopt healthier behaviors.
“The GLP-1s can spur weight loss and health benefits on their own, but the effects are larger and last longer when the drugs are combined with lifestyle changes, a recent review of nearly three dozen studies found.”
The drugs' effect "levels the playing field," according to Saunders, making it more manageable for individuals to implement healthier eating patterns and increase their physical activity levels. She further clarifies the perception often created by media and advertising.
“Social media and advertising sometimes create the impression that these medications are a quick fix, but obesity is a complex, chronic, progressive disease” that requires ongoing medical management, she added. Research into GLP-1 medications, such as Wegovy and Zepbound, has consistently incorporated structured lifestyle programs alongside the drug regimens. These integrated approaches are now recommended with every new prescription for these medications. The findings from these clinical trials demonstrate not only substantial weight loss but also significant improvements in various health markers.
A notable study conducted in February involving over 98,000 U.S. military veterans provided compelling evidence of the benefits of combining GLP-1 use with healthy habits. The research found that veterans who utilized a GLP-1 medication and adhered to six to eight healthy lifestyle habits experienced a 43% lower risk of serious cardiovascular events, including stroke and heart attack, compared to those who did not use the drugs and followed three or fewer such habits.
Dr. Frank Hu, a lead author of the study and chair of the nutrition department at the Harvard T.H. Chan School of Public Health, underscored the synergistic relationship between lifestyle and medication. “Lifestyle habits “can substantially amplify the benefits of modern medications” noted Dr. Frank Hu, a lead author and chair of the nutrition department at the Harvard T.H. Chan School of Public Health.”
To maximize the therapeutic advantages of GLP-1 drugs and concurrently mitigate potential side effects, such as nausea, vomiting, constipation, and muscle loss, experts offer specific guidance on essential lifestyle changes. These recommendations are designed to support overall well-being and enhance the effectiveness of the medication.
Maintaining adequate muscle mass is crucial, and experts advise consuming 20 to 30 grams of protein with each meal. This protein intake can be achieved through various food sources, including fish, poultry, yogurt, and beans. Increasing fiber consumption and ensuring sufficient hydration are also emphasized. Individuals are encouraged to drink between 8 to 12 cups of water daily. For those experiencing heartburn or nausea, avoiding fried and spicy foods is recommended, along with refraining from lying down immediately after meals.
Physical activity is another cornerstone of a healthy lifestyle. Experts suggest aiming for at least 150 minutes of aerobic exercise per week, which translates to approximately an hour of activity per day. In addition to aerobic exercise, incorporating 30 minutes of strength training two to three times a week is advised. This can involve activities such as lifting weights or using resistance bands to build and maintain muscle strength.
Adequate sleep is fundamental for overall health and recovery. Adults are recommended to get seven to nine hours of sleep per night. Furthermore, proactive steps should be taken to reduce mental and emotional stress, as chronic stress can negatively impact both physical and mental well-being.
Finally, consistent communication with a healthcare provider is essential throughout the course of treatment. Experts highlight that GLP-1 drugs, while generally safe, can have rare but serious side effects that require monitoring.
“Someone really does need to keeping track of: What is the pace of your weight loss? What are your side effects? And not just mailing you a prescription every month,” Dushay said. The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.